Nalaganje...

Clinical trial of sparfloxacin for lepromatous leprosy.

Nine previously untreated patients with lepromatous leprosy were treated with 200 mg of sparfloxacin daily for 12 weeks to determine whether this drug is bactericidal for Mycobacterium leprae in humans. The efficacy of therapy was monitored both clinically and by measuring changes in morphological i...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Chan, G P, Garcia-Ignacio, B Y, Chavez, V E, Livelo, J B, Jimenez, C L, Parrilla, M L, Franzblau, S G
Format: Artigo
Jezik:Inglês
Izdano: 1994
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC284397/
https://ncbi.nlm.nih.gov/pubmed/8141581
Oznake: Označite
Brez oznak, prvi označite!